IRLAB names Janne Backman board chair, replacing Carola Lemne
Bitget2026/09/24 15:33- IRLAB Therapeutics named Jan-Fredrik “Janne” Backman chairman, succeeding Carola Lemne, who stepped down in September.
- Backman was elected vice chairman at the 2026 annual general meeting.
- He previously held strategy, marketing, and R&D program leadership roles at The Medicines Company.
- Backman also held commercial positions at Merck Serono, AstraZeneca.
- He has served as CEO of J.F.B Consulting AB, J.F.B Invest since 2016.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Crypto prices
More
